Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanotubes | 2 | 2024 | 9 | 1.120 |
Why?
|
| Gentamicins | 2 | 2024 | 20 | 0.970 |
Why?
|
| Prosthesis-Related Infections | 2 | 2024 | 187 | 0.930 |
Why?
|
| Joint Prosthesis | 1 | 2024 | 89 | 0.850 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 166 | 0.790 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 380 | 0.780 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 78 | 0.660 |
Why?
|
| Osteoarthritis | 3 | 2017 | 335 | 0.570 |
Why?
|
| Signal Transduction | 3 | 2017 | 455 | 0.550 |
Why?
|
| Chitosan | 2 | 2024 | 9 | 0.440 |
Why?
|
| Pain | 1 | 2016 | 416 | 0.390 |
Why?
|
| Animals | 9 | 2024 | 3682 | 0.290 |
Why?
|
| Osteoarthritis, Spine | 2 | 2015 | 5 | 0.240 |
Why?
|
| Electroplating | 1 | 2024 | 3 | 0.230 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 73 | 0.220 |
Why?
|
| Low Back Pain | 2 | 2015 | 133 | 0.210 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2015 | 83 | 0.210 |
Why?
|
| Research Design | 1 | 2024 | 189 | 0.190 |
Why?
|
| Osteoarthritis, Knee | 2 | 2016 | 373 | 0.180 |
Why?
|
| Lumbar Vertebrae | 2 | 2015 | 391 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 290 | 0.160 |
Why?
|
| Mutation | 2 | 2017 | 353 | 0.150 |
Why?
|
| Zygapophyseal Joint | 2 | 2015 | 27 | 0.150 |
Why?
|
| Limb Deformities, Congenital | 1 | 2017 | 2 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 32 | 0.130 |
Why?
|
| Triamcinolone | 1 | 2016 | 6 | 0.130 |
Why?
|
| Protein Kinase C-delta | 1 | 2016 | 10 | 0.130 |
Why?
|
| Axons | 1 | 2016 | 28 | 0.120 |
Why?
|
| Hyperalgesia | 1 | 2016 | 48 | 0.120 |
Why?
|
| Treatment Outcome | 1 | 2024 | 3540 | 0.120 |
Why?
|
| Male | 3 | 2024 | 14887 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 369 | 0.120 |
Why?
|
| Scoliosis | 1 | 2015 | 35 | 0.120 |
Why?
|
| Interleukin-1 | 1 | 2014 | 49 | 0.110 |
Why?
|
| Joint Capsule | 1 | 2015 | 60 | 0.110 |
Why?
|
| Spondylolisthesis | 1 | 2015 | 42 | 0.110 |
Why?
|
| Arthralgia | 1 | 2016 | 135 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2015 | 317 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2014 | 77 | 0.110 |
Why?
|
| Intervertebral Disc | 1 | 2014 | 120 | 0.110 |
Why?
|
| Pain Measurement | 1 | 2015 | 486 | 0.100 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 419 | 0.100 |
Why?
|
| Inflammation | 1 | 2014 | 287 | 0.100 |
Why?
|
| Models, Animal | 2 | 2024 | 111 | 0.080 |
Why?
|
| Humans | 7 | 2024 | 27309 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 606 | 0.080 |
Why?
|
| Receptor, trkA | 2 | 2016 | 12 | 0.060 |
Why?
|
| Nerve Growth Factor | 2 | 2016 | 44 | 0.060 |
Why?
|
| Female | 3 | 2017 | 15334 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 454 | 0.060 |
Why?
|
| Ganglia, Spinal | 2 | 2016 | 61 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 375 | 0.050 |
Why?
|
| Rats | 2 | 2015 | 660 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 94 | 0.050 |
Why?
|
| Titanium | 1 | 2023 | 169 | 0.050 |
Why?
|
| Knee Joint | 2 | 2017 | 760 | 0.040 |
Why?
|
| Mice | 2 | 2016 | 1450 | 0.040 |
Why?
|
| Integrases | 1 | 2017 | 4 | 0.040 |
Why?
|
| Ectromelia | 1 | 2017 | 2 | 0.040 |
Why?
|
| Fibula | 1 | 2017 | 2 | 0.040 |
Why?
|
| Musculoskeletal Development | 1 | 2017 | 2 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Endothelium | 1 | 2017 | 14 | 0.040 |
Why?
|
| Collagen Type II | 1 | 2017 | 22 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2017 | 25 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2017 | 41 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 25 | 0.030 |
Why?
|
| Growth Plate | 1 | 2017 | 15 | 0.030 |
Why?
|
| Antibodies | 1 | 2017 | 46 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2017 | 23 | 0.030 |
Why?
|
| Bone Development | 1 | 2017 | 32 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 110 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 55 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2017 | 137 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2017 | 104 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 63 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2016 | 4 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 12 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 28 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2017 | 155 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 119 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Celecoxib | 1 | 2015 | 6 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 93 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2016 | 56 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 44 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 33 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 44 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 672 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 146 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 153 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 61 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2014 | 20 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 21 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 328 | 0.030 |
Why?
|
| Cattle | 1 | 2014 | 124 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 51 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 122 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 41 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 169 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 70 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 133 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 185 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 643 | 0.030 |
Why?
|
| Cadaver | 1 | 2015 | 375 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 238 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2014 | 311 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2014 | 527 | 0.030 |
Why?
|
| Young Adult | 1 | 2015 | 2032 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4841 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 7946 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 9068 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 9119 | 0.010 |
Why?
|